Whitehawk Therapeutics, Inc.
Qualité des données : 100%
WHWK
Nasdaq
Manufacturing
Chemicals
3,39 €
▼
0,16 €
(-4,51%)
Cap. Boursière: 160,00 M
Prix
3,39 €
Cap. Boursière
160,00 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue grew 58,93% annually over 5 years — strong growth
Negative free cash flow of -97,99 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 131,43%
Capital efficient — spends only 7,73% of revenue on capex
Croissance
Revenue Growth (5Y)
58,93%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)-72,50%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-12,51%
Au-dessus de la moyenne du secteur (-53,53%)
ROIC-54,90%
Net Margin-288,26%
Op. Margin-1601,12%
Sécurité
Debt / Equity
N/A
Current Ratio16,76
Interest CoverageN/A
Valorisation
PE (TTM|NTM)
-7,77 | -2,83
En dessous de la moyenne du secteur (-1,48)
P/B Ratio1,02
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1366 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1366 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,8 | -1,5 |
| P/B | 1,0 | 1,6 |
| ROE % | -12,5 | -53,5 |
| Net Margin % | -288,3 | -41,5 |
| Rev Growth 5Y % | 58,9 | 1,8 |
| D/E | — | 0,3 |
Objectif de Cours des Analystes
3 analystes
Hold
Actuel
3,39 €
Objectif
5,67 €
4,00 €
6,00 €
7,00 €
Prévisions
P/E Prévisionnel
-2,83
BPA Prévisionnel
-1,20 €
CA Est.
0,0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
-1,20 €
-1,20 € – -1,20 €
|
0,0 | 1 |
| FY2026 |
-1,27 €
-1,37 € – -1,16 €
|
0,0 | 2 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
-0,31 €
-0,34 € – -0,27 €
|
0,0 | 2 |
| 2026 Q1 |
-0,31 €
-0,33 € – -0,29 €
|
0,0 | 2 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,27 € | -0,34 € | -25,9% |
| Q32025 | -0,22 € | -0,25 € | -15,4% |
| Q22025 | -0,17 € | -0,76 € | -347,1% |
| Q12025 | -0,23 € | -0,36 € | -58,2% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -72,50% | Revenue Growth (3Y) | -45,84% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 58,93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7,15 M | Net Income (TTM) | -20,60 M |
| ROE | -12,51% | ROA | -11,84% |
| Gross Margin | N/A | Operating Margin | -1601,12% |
| Net Margin | -288,26% | Free Cash Flow (TTM) | -97,99 M |
| ROIC | -54,90% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 16,76 |
| Interest Coverage | N/A | Asset Turnover | 0,04 |
| Working Capital | 155,19 M | Tangible Book Value | 157,17 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7,77 | Forward P/E | -2,83 |
| P/B Ratio | 1,02 | P/S Ratio | 22,39 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -61,24% | ||
| Market Cap | 160,00 M | Enterprise Value | 122,07 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,33 | Revenue / Share | 0,15 |
| FCF / Share | -2,08 | OCF / Share | -2,06 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 7,73% | FCF Conversion | 475,75% |
| SBC-Adj. FCF | -108,03 M | Growth Momentum | -131,43 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7,15 M | 25,98 M | 24,35 M | 15,22 M | 1,12 M |
| Net Income | -20,60 M | -63,69 M | -65,77 M | -60,51 M | -110,09 M |
| EPS (Diluted) | -0,33 | -2,36 | -2,44 | -2,69 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -114,40 M | -67,46 M | -71,93 M | -62,68 M | -111,22 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 90,96 M | 51,03 M | 48,93 M | 32,66 M | 19,67 M |
| SG&A Expenses | 29,82 M | 36,75 M | 44,55 M | 40,18 M | — |
| D&A | 79 000,0 | 193 000,0 | 169 000,0 | 159 000,0 | 105 000,0 |
| Interest Expense | 0,0 | 154 000,0 | 231 000,0 | 230 000,0 | 665 000,0 |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 2 000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 150,83 M | 70,32 M | 132,42 M | 184,24 M | 157,91 M |
| Total Liabilities | 14,52 M | 17,84 M | 27,23 M | 25,86 M | 21,50 M |
| Shareholders' Equity | 136,31 M | 52,48 M | 105,20 M | 158,38 M | 136,41 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 37,57 M | 28,67 M | 62,89 M | 39,02 M | 148,99 M |
| Current Assets | 149,01 M | 61,29 M | 124,59 M | 180,03 M | 151,27 M |
| Current Liabilities | 14,52 M | 17,07 M | 26,40 M | 18,84 M | 15,27 M |
{"event":"ticker_viewed","properties":{"ticker":"WHWK","listing_kind":"stock","pathname":"/stocks/whwk","exchange":"Nasdaq","country":"US"}}